Company intelligence / Profile preview

Mark Cuban Cost Plus Drug Company

Dallas, Texas, United Statescostplusdrugs.com ↗

Ownership: Private
Development stage: Commercial

Overview

The company offers over 2,200–2,500 generic medications at transparent cost-plus pricing directly to consumers in all U.S. states. It has begun in-house manufacturing of sterile injectable generics to address shortages and high prices. No clinical trial results are relevant as the company does not develop new drugs but manufactures/distributes approved generics.

Therapeutic areas: GastroenterologyCardiovascularPsychiatryEndocrinologyOtherOncology
Modalities: Small moleculeBiologic
Industry: Non-Academic Healthcare

Partnerships

Truepill Pharmacy (pharmacy fulfillment partner)Multiple insurance PBMs/networks for limited insurance acceptanceDirect relationships with various drug manufacturers (~10 brand manufacturers per recent statements)

Beyond the preview

Go deeper on Mark Cuban Cost Plus Drug Company.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mark Cuban Cost Plus Drug Company.

Explore the full profile